Opendata, web and dolomites


high-performance BIOPLAStic PROducts for new markets and applications

Total Cost €


EC-Contrib. €






Project "BIOPLAS-PRO" data sheet

The following table provides information about the project.


Organization address
address: CORSO VENEZIA 36
city: MILANO
postcode: 20121
website: n.a.

contact info
title: n.a.
name: n.a.
surname: n.a.
function: n.a.
email: n.a.
telephone: n.a.
fax: n.a.

 Coordinator Country Italy [IT]
 Project website
 Total cost 71˙429 €
 EC max contribution 50˙000 € (70%)
 Programme 1. H2020-EU.2.1.5. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced manufacturing and processing)
2. H2020-EU.2.1.3. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies - Advanced materials)
3. H2020-EU.2.3.1. (Mainstreaming SME support, especially through a dedicated instrument)
4. H2020-EU.2.1.2. (INDUSTRIAL LEADERSHIP - Leadership in enabling and industrial technologies – Nanotechnologies)
 Code Call H2020-SMEINST-1-2016-2017
 Funding Scheme SME-1
 Starting year 2017
 Duration (year-month-day) from 2017-12-01   to  2018-04-30


Take a look of project's partnership.

# participants  country  role  EC contrib. [€] 
1    SINECO INTERNATIONAL SRL IT (MILANO) coordinator 50˙000.00


 Project objective

Environmental awareness, limited oil reserves and EU legislations are driving the need for eco-friendly alternatives to synthetic plastics. In this context, we present BIOPLAS-PRO, project aiming at developing and commercializing high-performance and cost-effective bioplastic products for the civil and advanced composite industry that contain more than 95% of starch-based biopolymers, are 100% eco-friendly, recyclable and O-degradable. Envisioned products include BIO-MAT and BIO-DRAIN, 3D structured mats for soil stabilization, erosion control and water drainage control, and BIO-CORE, a 2D/3D structured spacer and resin flow media used in composite products. Our products are produced by our unique isotropic extrusion-moulding process ensuring the best biopolymer processing conditions and highest quality products. We are the first company in the world to have successfully adapted this extrusion-moulding process to bioplastics.

The Phase I feasibility study is required to set-up detailed product and production scale-up requirements and ensure the overall commercial viability of the project.

The end users of our products are construction companies and enterprises manufacturing composite products. Their needs are high quality products and low environmental impacts. Our products provide similar or better performance to existing synthetic and/or natural solutions, are made 100% from renewable resources and have controlled biodegradability (100% degradation in 1-5 years). Within the first 5 years, we estimate to sell 13 kton of products, which will generate €30 million of accumulated revenues while reducing plastic waste by 10 kton and CO2 emission by 32 kton. This is perfectly in-line with EU strategies on reducing the use of harmful materials and improving waste management.

Are you the coordinator (or a participant) of this project? Plaese send me more information about the "BIOPLAS-PRO" project.

For instance: the website url (it has not provided by EU-opendata yet), the logo, a more detailed description of the project (in plain text as a rtf file or a word file), some pictures (as picture files, not embedded into any word file), twitter account, linkedin page, etc.

Send me an  email ( and I put them in your project's page as son as possible.

Thanks. And then put a link of this page into your project's website.

The information about "BIOPLAS-PRO" are provided by the European Opendata Portal: CORDIS opendata.

More projects from the same programme (H2020-EU.2.1.5.;H2020-EU.2.1.3.;H2020-EU.2.3.1.;H2020-EU.2.1.2.)


Super Productive Line Printing Inkjet

Read More  

HelpingHAND (2018)

A 3D printed, affordable myoelectrical prosthetic hand of personalizeable size for optimal comfort and functionality

Read More  

HIL PT System (2017)

Revolutionary, cost effective, spatially efficient, proton therapy system for cancer treatment.

Read More